CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
Experimental: Verum TMS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02223767
NCT02223767N/ACompleted
CompareCT.gov

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Height Phobics

Wuerzburg University Hospital·interventional·Posted Aug 22, 2014·Updated Aug 2, 2023

In Brief

A clinical study evaluating Experimental: Verum TMS and Experimental: Sham TMS for Phobia. Completed, enrolled 47 participants across 1 site.

Detailed Summary

This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realized in virtual reality. Before and after therapy, the phobic symptoms were measured on a subjective, behavioral and physiological level. The placebo-controlled single blinded study includes 50 phobic patients, which were randomized into verum or sham TMS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPhobia
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 22, 2014
Enrollment StartAug 1, 2014
Primary CompletionApr 1, 2015
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.9 years ago

Interventions

Experimental: Verum TMSdevice

Intensity of 100 % of the resting motor threshold with 10 Hz and intertrial interval (ITI) of 26 s. 1560 pulse in 40 trains at all . One train lasts 4 s.

Experimental: Sham TMSdevice

Sham stimulation with 10 Hz and ITI of 26 s. 1560 pulse in 40 trains at all . One train lasts 4 s.